Inventor · disambiguated record
Emmanuel Nony
Also filed as: NONY EMMANUEL
29 granted patents·7 pending applications·186 citations·filing 2001–2017
96Inventor score
Files withLAB FRANCAIS DU FRACTIONNEMENT13LFB BIOTECHNOLOGIES6BELIARD ROLAND5STALLERGENES3MOINGEON PHILIPPE2
Top patents by PatentIndex Score
36 records- 0196US7931895B2Monoclonal antibodies with enhanced ADCC functionLFB BIOTECHNOLOGIES·Filed 2005·Granted Apr 26, 2011·36 cites·22 claims
- 0295US8685725B2Monoclonal antibodies with enhanced ADCC functionBELIARD ROLAND·Filed 2011·Granted Apr 1, 2014·24 cites·26 claims
- 0394US8409572B2Monoclonal antibodies with enhanced ADCC functionBELIARD ROLAND·Filed 2012·Granted Apr 2, 2013·17 cites·19 claims
- 0494US7579170B2Method for preparing monoclonal antibodies capable of activating effector cells expressing FCγRIIILAB FRANCAIS DU FRACTIONNEMENT·Filed 2001·Granted Aug 25, 2009·44 cites·9 claims
- 0590US7713524B2Use of ADCC-optimized antibodies for treating low-responder patientsLFB BIOTECHNOLOGIES·Filed 2004·Granted May 11, 2010·34 cites·10 claims
- 0684US7541029B2Anti-rhesus D monoclonal antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2006·Granted Jun 2, 2009·4 cites·4 claims
- 0783US8501171B2Use of ADCC-optimized antibodies for treating weak patientsBOUREL DOMINIQUE·Filed 2010·Granted Aug 6, 2013·9 cites·10 claims
- 0883US8153124B2Method for treating cancer using monoclonal antibodiesBELIARD ROLAND·Filed 2009·Granted Apr 10, 2012·3 cites·22 claims
- 0977US9708409B2Monoclonal antibodies with enhanced ADCC functionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Granted Jul 18, 2017·1 cites·16 claims
- 1076US9718890B2Monoclonal antibodies with enhanced ADCC functionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Aug 1, 2017·1 cites·20 claims
- 1175US10364425B2Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan unitsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Granted Jul 30, 2019·2 cites·11 claims
- 1275US9718889B2Monoclonal antibodies with enhanced ADCC functionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Aug 1, 2017·1 cites·27 claims
- 1374US10344272B2Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan unitsCHTOUROU ABDESSATAR SAMI·Filed 2007·Granted Jul 9, 2019·2 cites·10 claims
- 1471US8124078B2Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodiesBELIARD ROLAND·Filed 2009·Granted Feb 28, 2012·0 cites·25 claims
- 1570US8178093B2Method for treating infectious disease using monoclonal antibodiesBELIARD ROLAND·Filed 2009·Granted May 15, 2012·0 cites·22 claims
- 1669US10081683B2Monoclonal antibodies with enhanced ADCC functionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2017·Granted Sep 25, 2018·0 cites·14 claims
- 1768US8632993B2Method for grass species identificationMOINGEON PHILIPPE·Filed 2010·Granted Jan 21, 2014·2 cites·4 claims
- 1866US2009239788A1Recombinant or transgenic factor vii compound having a majority of glycan, biantennary, bisialylated and non-fucosylated formsLFB BIOTECHNOLOGIES·Filed 2007·Application pending·0 cites
- 1964US8357370B2Anti-D monoclonal antibodiesLFB BIOTECHNOLOGIES·Filed 2012·Granted Jan 22, 2013·0 cites·16 claims
- 2061US9109020B2Use of ADCC-optimized antibodies for treating weak patientsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Granted Aug 18, 2015·0 cites·10 claims
- 2159US10101341B2Biomarkers of immunotherapy efficacyBODO VERONIQUE·Filed 2012·Granted Oct 16, 2018·2 cites·16 claims
- 2259US9187568B2Use of IgG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal routeBATARD THIERRY·Filed 2010·Granted Nov 17, 2015·1 cites·15 claims
- 2359US7790399B2Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptorsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2004·Granted Sep 7, 2010·1 cites·13 claims
- 2458US2010323368A1Cytokine production-inducing antibodyLAB FRANCAIS DU FRACTIONNEMENT·Filed 2009·Application pending·0 cites
- 2556US7595165B2Method of measuring activation of effector cellsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2003·Granted Sep 29, 2009·2 cites·1 claims
- 2656US2013189244A1Recombinant or transgenic factor vii compound having a majority of glycan, biantennary, bisialylated and non-fucosylated formsLFB BIOTECHNOLOGIES·Filed 2012·Application pending·0 cites
- 2754US9879089B2Use of ADCC-optimized antibodies for treating low-responder patientsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Jan 30, 2018·0 cites·14 claims
- 2847US2007015239A1Correlation between the fucose content/galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activityLAB FRANCAIS DU FRACTIONNEMENT·Filed 2004·Application pending·0 cites
- 2945US9822185B2Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosaSTALLERGENES SA·Filed 2015·Granted Nov 21, 2017·0 cites·4 claims
- 3044US2011162094A1Modified human factor vii/viia and pharmaceutical composition containing the sameLFB BIOTECHNOLOGIES·Filed 2008·Application pending·0 cites
- 3143US10190166B2Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapyMOINGEON PHILIPPE·Filed 2012·Granted Jan 29, 2019·0 cites·4 claims
- 3239US2015210742A1Novel allergen from ragweed pollen and uses thereofSTALLERGENES SA·Filed 2013·Application pending·0 cites
- 3337US11015221B2Markers of immune responseSTALLERGENES·Filed 2015·Granted May 25, 2021·0 cites·3 claims
- 3436US2017157240A1Composition of allergen extracts having reduced toxicity and method of production thereofSTALLERGENES·Filed 2015·Application pending·0 cites
- 3533US10884002B2Sialylated fetuin-A as a marker of immunotherapy efficacySTALLERGENES·Filed 2015·Granted Jan 5, 2021·0 cites·8 claims
- 3622US9868770B2Recombinant Der P 2 expressed in Pichia Pastoris as a “natural-like” allergen for immunotherapy and diagnostic purposesBORDAS VÉRONIQUE·Filed 2011·Granted Jan 16, 2018·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Emmanuel Nony files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →